Clinical trial · Interventional
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors
Pilot Study of a Social/Behavioral Intervention on Cancer Survivors, Evaluating the Effect of Mind Body Interventions on Patient Reported Outcomes, Inflammation and Epigenetics.
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cancer survivors can experience health issues that cause chronic illness and lower quality of life. Yoga is a well-known holistic approach to health and overall well-being. Mindfulness has many benefits, including improved focus and less stress. This study aims to evaluate if yoga and/or mindfulness has a positive effect on cancer survivors social, emotional and physical well-being as well as their epigenetics. Epigenetics is how the environment can effect your genes; not by changing our DNA, but by turning genes on or off.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Survivors | — | UNRESOLVED | — |
| Cancer Survivorship | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Oncology-informed yoga | Behavioral | — | UNRESOLVED |
| SMART | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Yoga
- description
- Oncology-informed yoga
- interventionNames
- Behavioral: Oncology-informed yoga
- type
- EXPERIMENTAL
- label
- SMART
- description
- Stress Management and Resiliency Training
- interventionNames
- Behavioral: SMART
Primary outcomes (26)
- measure
- Patient Reported Quality of Life (QOL) by EORTC QLQ-C30
- timeFrame
- 8 weeks
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Adults over 18 years old * Primary diagnosis: Lung Cancer, Colon Cancer and Non-Hodgkin's lymphoma (NHL) * Six months post cancer-directed treatment (chemotherapy, targeted and immunotherapy). Patients with active disease (e.g. metastatic colorectal cancer) who are not receiving any cancer-directed treatment are eligible. * Able to provide a saliva sample * Gives informed consent and agrees to be randomly assigned * Able to complete the questionnaire(s) in English. Exclusion Criteria: * Adults with primary anal and/or primary rectal cancer. * Adult cancer survivors who are currently on an active treatment regimen. * Oral or any pathological conditions that can limit the ability to produce saliva. * Unable to participate in full length study period and follow up thereafter. * Is pregnant or plan to become pregnant during the study period. * Currently practicing yoga or SMART * Those on corticosteroid therapy. * Documented fall or syncope within the last 6 months
References
Publications (0)
Data not yet available